Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can active immunization redirect an anti-IgE immune response?

B M Stadler1, M P Rudolf, M Vogel

  • 1Institute of Immunology and Allergology, Inselspital, Bern, Switzerland. stadler@insel.unibe.ch

International Archives of Allergy and Immunology
|May 1, 1997
PubMed
Summary

Researchers developed novel IgE mimotopes using phage display, offering a potential new vaccine for allergies. These peptides mimic key parts of immunoglobulin E (IgE), aiming to induce a beneficial autoimmune response and reduce allergy symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins.

European cells & materials·2014
Same author

Increased level of antibodies cross-reacting with Ves v 5 and CRISP-2 in MAR-positive patients.

International archives of allergy and immunology·2012
Same author

Molecular characterization of melanoma-derived antigens.

Methods in molecular medicine·2012
Same author

Cross-reactions vs co-sensitization evaluated by in silico motifs and in vitro IgE microarray testing.

Allergy·2011
Same author

Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.

The Journal of antimicrobial chemotherapy·2011
Same author

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.

Allergy·2011

Area of Science:

  • Immunology
  • Allergy Research
  • Vaccine Development

Background:

  • Immunoglobulin E (IgE) plays a central role in allergic reactions.
  • Current anti-IgE therapies show promise but have limitations.
  • Developing new strategies for IgE-mediated allergy treatment is crucial.

Purpose of the Study:

  • To isolate and characterize peptides (mimotopes) that mimic human IgE epitopes.
  • To evaluate the potential of these IgE mimotopes as active vaccination agents.
  • To explore the development of anti-idiotypic antibodies for allergy immunotherapy.

Main Methods:

  • Utilized a mouse monoclonal antibody against IgE as a template.
  • Employed random peptide phage display libraries for mimotope isolation.

Related Experiment Videos

  • Investigated anti-idiotypic antibodies from antibody phage display libraries.

    • Main Results:

    • Successfully isolated two distinct types of IgE mimotopes targeting different epitopes.
    • Demonstrated that these mimotopes, when conjugated with carriers, could induce an autoimmune response.
    • Confirmed that isolated anti-idiotypic antibodies were inhibited by the IgE mimotopes.

    Conclusions:

    • Isolated IgE mimotopes show potential as a safe and effective active vaccination strategy.
    • This approach may lead to a new generation of follow-up drugs for anti-IgE therapies.
    • Defined IgE mimotopes offer a promising avenue for treating IgE-mediated allergic diseases.